Determinants of cholesterol efflux capacity in humans

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Molecular Biology

Background:

• High-density lipoproteins (HDL) are crucial for reverse cholesterol transport (RCT).
• The traditional view of HDL-cholesterol (HDL-C) lowering cardiovascular disease (CVD) risk is being re-evaluated.
• Improving HDL's cholesterol efflux capacity is a promising strategy for CVD prevention.

Purpose of the Study:

• To review assays for quantifying HDL-mediated cholesterol efflux.
• To discuss factors influencing HDL-mediated cholesterol efflux.
• To explore the relationship between cholesterol efflux capacity and CVD risk.

Main Methods:

• Review of existing literature on HDL cholesterol efflux assays.
• Analysis of factors affecting HDL-mediated cholesterol efflux, including particle characteristics, subject demographics, drugs, lifestyle, genetics, and inflammation.
• Discussion of the role of ABC-transporters in cholesterol efflux.

Main Results:

• Small HDL particles efficiently promote cholesterol efflux via the ABCA1 transporter.
• This finding contrasts with epidemiological studies linking larger HDL2 particles to reduced CVD risk.
• Multiple factors influence HDL-mediated cholesterol efflux.

Conclusions:

• Cholesterol efflux capacity, rather than HDL-C levels alone, is a critical target for CVD prevention.
• Understanding the complex interplay of factors affecting efflux capacity is essential.
• Further research is needed to establish causality between cholesterol efflux capacity and CVD risk reduction.